These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3715796)

  • 21. Prevention of deep vein thrombosis following total hip replacement surgery by Orgaran. Summary.
    ten Cate JW
    Haemostasis; 1992; 22(2):109-11. PubMed ID: 1379964
    [No Abstract]   [Full Text] [Related]  

  • 22. Successful use of the APTT in monitoring of the anti-factor Xa activity of the heparinoid organon 10172 in a case of HITS requiring open heart surgery.
    Marshall LR; Cannell PK; Herrmann RP
    Thromb Haemost; 1992 May; 67(5):587. PubMed ID: 1519220
    [No Abstract]   [Full Text] [Related]  

  • 23. Comparison of two experimental thrombosis models in rats effects of four glycosaminoglycans.
    Vogel GM; Meuleman DG; Bourgondiën FG; Hobbelen PM
    Thromb Res; 1989 Jun; 54(5):399-410. PubMed ID: 2549654
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Subcutaneous heparin for thrombosis in pregnant women with hereditary antithrombin deficiency.
    Brandt P; Stenbjerg S
    Lancet; 1979 Jan; 1(8107):100-1. PubMed ID: 84100
    [No Abstract]   [Full Text] [Related]  

  • 25. Effective prophylaxis with oral anticoagulants and low-dose heparin during pregnancy in an antithrombin III deficient woman.
    Vellenga E; van Imhoff GW; Aarnoudse JG
    Lancet; 1983 Jul; 2(8343):224. PubMed ID: 6135060
    [No Abstract]   [Full Text] [Related]  

  • 26. The effectiveness of a low molecular weight heparinoid in chronic intermittent haemodialysis.
    Henny CP; ten Cate H; Surachno S; Stevens P; Büller HR; den Hartog M; ten Cate JW
    Thromb Haemost; 1985 Aug; 54(2):460-2. PubMed ID: 2417351
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of a low molecular weight preparation of heparin--ORG 10172 (Lomoparan) in the critically ill.
    John G; Shehabi Y; Mudaliar Y
    Anaesth Intensive Care; 1991 Nov; 19(4):588-91. PubMed ID: 1721505
    [No Abstract]   [Full Text] [Related]  

  • 28. [A hypercoagulation syndrome in pregnancy due to an antithrombin III defect].
    Janků K; Penka M
    Cesk Gynekol; 1990 Nov; 55(9):657-60. PubMed ID: 2093449
    [No Abstract]   [Full Text] [Related]  

  • 29. [Thrombosis therapy and the prophylaxis of thrombosis recurrences in obstetrics].
    Voigt T; Voigt H; Wegner H; Scheel H
    Z Gesamte Inn Med; 1981 Jun; 36(12):418-21. PubMed ID: 7303769
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A randomized blind study comparing standard heparin and a new low molecular weight heparinoid in cardiopulmonary bypass surgery in dogs.
    Henny CP; Ten Cate H; Ten Cate JW; Moulijn AC; Sie TH; Warren P; Büller HR
    J Lab Clin Med; 1985 Aug; 106(2):187-96. PubMed ID: 4020247
    [TBL] [Abstract][Full Text] [Related]  

  • 31. "Heparin-free" cardiopulmonary bypass: first reported use of heparinoid (Org 10172) to provide anticoagulation for cardiopulmonary bypass.
    Doherty DC; Ortel TL; de Bruijn N; Greenberg CS; Van Trigt P
    Anesthesiology; 1990 Sep; 73(3):562-5. PubMed ID: 1697448
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prophylaxis of thrombosis in antithrombin III-deficient women during pregnancy and delivery.
    Michiels JJ; Stibbe J; Vellenga E; van Vliet HH
    Eur J Obstet Gynecol Reprod Biol; 1984 Oct; 18(3):149-53. PubMed ID: 6500155
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fixed mini-dose warfarin for prophylaxis of thromboembolic disease in pregnancy: a safe alternative for the fetus?
    Porreco RP; McDuffie RS; Peck SD
    Obstet Gynecol; 1993 May; 81(5 ( Pt 2)):806-7. PubMed ID: 8469479
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Can low molecular weight heparins and heparinoids be safely given to patients with heparin-induced thrombocytopenia syndrome?
    Kikta MJ; Keller MP; Humphrey PW; Silver D
    Surgery; 1993 Oct; 114(4):705-10. PubMed ID: 7692613
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of pregnancy in women with antithrombin III congenital defect: report of four cases.
    De Stefano V; Leone G; De Carolis S; Ferrelli R; Di Donfrancesco A; Moneta E; Bizzi B
    Thromb Haemost; 1988 Apr; 59(2):193-6. PubMed ID: 3164529
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heparin-induced thrombocytopenia: studies with a new low molecular weight heparinoid, Org 10172.
    Chong BH; Ismail F; Cade J; Gallus AS; Gordon S; Chesterman CN
    Blood; 1989 May; 73(6):1592-6. PubMed ID: 2713496
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prophylaxis of thromboembolism during pregnancy in hereditary AT-III deficiency.
    Brenner B; Tavori S; Tatarsky I
    Am J Hematol; 1992 Jan; 39(1):71-2. PubMed ID: 1536145
    [No Abstract]   [Full Text] [Related]  

  • 38. The pregnant antithrombin III deficient patient: management without antithrombin III concentrate.
    Blondel-Hill E; Mant MJ
    Thromb Res; 1992 Jan; 65(2):193-8. PubMed ID: 1579895
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevention of deep vein thrombosis following total hip replacement by low molecular weight heparinoid.
    Hoek JA; Nurmohamed MT; Hamelynck KJ; Marti RK; Knipscheer HC; ten Cate H; Büller HR; Magnani HN; ten Cate JW
    Thromb Haemost; 1992 Jan; 67(1):28-32. PubMed ID: 1615479
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of a new heparinoid as anticoagulant during acute haemodialysis of patients with bleeding complications.
    Henny CP; Ten Cate H; Ten Cate JW; Surachno S; van Bronswijk H; Wilmink JM; Ockelford PA
    Lancet; 1983 Apr; 1(8330):890-3. PubMed ID: 6132219
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.